Insider Trading activities of Ngm Biopharmaceuticals Inc (NGM)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ngm Biopharmaceuticals Inc (NGM) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ngm Biopharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Ngm Biopharmaceuticals Inc since 2005. The reporting company's ticker symbol is NGM. The reporting company's CIK number is 1426332.
The total value of stock buying since 2005 is $165,035,911.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Ngm Biopharmaceuticals Inc (NGM).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-06 235,380 $3,236,184 0 $0 0 $0
2019-05 374,769 $5,180,799 0 $0 0 $0
2019-04 9,788,683 $156,618,928 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Ngm Biopharmaceuticals Inc insiders (NGM)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-06-14 Kutzkey Tim (10% Owner) Buy 10,760 14.00 150,683
2019-06-14 Svennilson Peter (Director) Buy 10,760 14.00 150,683
2019-06-14 Goeddel David V (Director) Buy 10,760 14.00 150,683
2019-06-13 Kutzkey Tim (10% Owner) Buy 11,500 14.13 162,506
2019-06-13 Svennilson Peter (Director) Buy 11,500 14.13 162,506
2019-06-13 Goeddel David V (Director) Buy 11,500 14.13 162,506
2019-06-12 Kutzkey Tim (10% Owner) Buy 7,500 14.00 104,992
2019-06-12 Svennilson Peter (Director) Buy 7,500 14.00 104,992
2019-06-12 Goeddel David V (Director) Buy 7,500 14.00 104,992
2019-06-11 Kutzkey Tim (Other) Buy 10,900 13.83 150,714
2019-06-11 Svennilson Peter (Director) Buy 10,900 13.83 150,714
2019-06-11 Goeddel David V (Director) Buy 10,900 13.83 150,714
2019-06-07 Kutzkey Tim (Other) Buy 12,600 13.66 172,179
2019-06-07 Svennilson Peter (Director) Buy 12,600 13.66 172,179
2019-06-07 Goeddel David V (Director) Buy 12,600 13.66 172,179
2019-06-06 Kutzkey Tim (Other) Buy 12,600 13.40 168,890
2019-06-06 Svennilson Peter (Director) Buy 12,600 13.40 168,890
2019-06-06 Goeddel David V (Director) Buy 12,600 13.40 168,890
2019-06-04 Kutzkey Tim (Other) Buy 12,600 13.39 168,764
2019-06-04 Svennilson Peter (Director) Buy 12,600 13.39 168,764
2019-06-04 Goeddel David V (Director) Buy 12,600 13.39 168,764
2019-05-20 Kutzkey Tim (Other) Buy 50,000 13.50 675,000
2019-05-20 Svennilson Peter (Director) Buy 50,000 13.50 675,000
2019-05-20 Goeddel David V (Director) Buy 50,000 13.50 675,000
2019-05-10 Kutzkey Tim (Other) Buy 17,923 13.85 248,233
2019-05-10 Svennilson Peter (Director) Buy 17,923 13.85 248,233
2019-05-10 Goeddel David V (Director) Buy 17,923 13.85 248,233
2019-05-07 Kutzkey Tim (Other) Buy 57,000 14.10 803,700
2019-05-07 Svennilson Peter (Director) Buy 57,000 14.10 803,700
2019-05-07 Goeddel David V (Director) Buy 57,000 14.10 803,700
2019-04-08 Kutzkey Tim (Other) Buy 1,890,000 16.00 30,240,000
2019-04-08 Svennilson Peter (Director) Buy 1,895,000 16.00 30,320,000
2019-04-08 Hooper Suzanne Sawochka (Director) Buy 7,000 16.00 112,000
2019-04-08 Goeddel David V (Director) Buy 1,875,000 16.00 30,000,000
2019-04-08 Merck Sharp & Dohme Corp. (10% Owner) Buy 4,121,683 16.00 65,946,928

Insider trading activities including stock purchases, stock sales, and option exercises of NGM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ngm Biopharmaceuticals Inc (symbol NGM, CIK number 1426332) see the Securities and Exchange Commission (SEC) website.